China2016 P4 Precision Medical Annual Summary of The General Assembly

The precise medical idea old but hot, scientific research, clinical and industrial achievements, the contention of a hundred schools of thought. However, in the face of precise medical system engineering, the times on one side force alone is already in the past, collaborative, down-to-earth, steady, in order to successfully P4 medical and biological economy era sounded the clarion call of the time, to capture data, to crush the "bubble", improve the industry supporting industry, to solve technical problems.
On -18 December 16th, sponsored by the society of biological engineering, China Chinese Research Hospital Association and the Shanghai Business Information Consulting Co. Ltd., Chinese American biotechnology and Pharmaceutical Research Association, Taiwan Biotechnology Development Association, EPMA, jointly organized P4 China2016 international precision medical congress. The general assembly to invite you to learn and progress together to create precision medical future.

First, the composition of the general assembly
Development opportunities and strategic layout of precision medical treatment at home and abroad (main venue 12.16)
Multi - group and Systems Biology Forum (12.17-18)
Clinical molecular diagnostic technology development and Application Forum (two 12.17-18)
Precision medicine research and Development Forum (three 12.17-18)

Two, academic Steering Committee of the general assembly (still in the increase)
Li XK, President of Wenzhou University, Professor
Hua Zi Chun, executive director, School of life science, Nanjing University, Professor
Zhang Junfeng, College of life sciences, Nanjing University, Professor
Lin Shengcai, Dean, College of life sciences, Xiamen University, Professor
Liu Jing, vice president of the First Affiliated Hospital, Dalian Medical University, Professor

Three, guest speaker
(a) speech on the line of scientific research:
Han Bok-Ghee, director of the center for genetic science, Korea National Institutes of health
Hermjakob Henning, head of the European Institute for molecular systems, European Institute for molecular biology
L vy e Yves, President of the French national life science and Health Alliance (Aviesan), the national precision medical major special implementation of the person in charge
Hubbard Tim, UK Sanger Institute WellcomeTrust biological information person in charge
Zhang Zhiyuan, senior research fellow, Beijing Life Science Research Institute, director of the center for technology transfer
Wang Xinjing, director of the DNA diagnostic laboratory, the National Institutes of health
(two) speech on clinical line:
Lv Youyong, Beijing Cancer Hospital, Beijing Institute of cancer prevention and control
Zhan Xianquan, deputy director, laboratory of Xiangya Hospital, Central South University
Kang Xixiong, director, Department of laboratory, Beijing Tiantan Hospital, Capital Medical University
Han Weidong, director of the Department of biological therapy, 301 Hospital of the people's Liberation Army
Shi Huaiyin, director of the General Hospital of Armed Police General Hospital, Yang Xiaoli, executive director of the General Hospital of PLA
(three) pharmaceutical R & D line speakers:
Yang Hongjun, AstraZeneca and biomarkers for personalized treatment of head of research and development and chief technology officer
Keep the nest Parkinson, senior vice president of AstraZeneca
Rupalla Katrin, when the United States and the United States, vice president of the United States and China research and development director Wang Zaiqi,
Merck China, executive director of clinical research
Li Zonghai, (Shanghai) Co. Cozi bio pharmaceutical company president
Xie Zhiyi, medical director of the Limited by Share Ltd
Gong Zhaolong, the idea of CO CEO, former FDA senior drug reviewers
Qiu Jianping, executive vice president of Wuhan youzhiyou Biological Pharmaceutical Co Ltd
Liu Bizuo, Xibiman biotechnology CEO
Niu Hongsen, a founding partner of bluestone capital

Three, the venue features
(a) domestic and foreign precision medical development opportunities and strategic layout (main venue 12.16)
In Europe, America and Asia precision medical field leading practice leader representative countries, the latest progress in precision medical
A large collection of roundtable discussions, academia, industry, capital, etc. a lot of hospital clinicians absolute level figures
From the perspective of enterprises, combined with the policy environment, the thermal technology, capital opportunities, big data technology, contention of a hundred schools of thought

(two) multi group and System Biology Forum (12.17-18)
Forum features: multi - group and system biology academic research is the basis for precision medicine. From the basic construction of systems biology; life group science and technology development and application; application of information and computational biology; systems biology in cancer research in the application of the four major themes of starting the most value of learning topics.
You will see: systems biology, life science and technology, biological physics, Bioinformatics Institute, genetics, genomics, research institutions, Basic Medical Sciences
(three) clinical molecular diagnostic technology development and Application Forum (two 12.17-18)
The forum features: a novel molecular diagnostic technology of a new generation of sequencing, liquid biopsy technique has been an unprecedented development in clinical practice and application, but its clinical development and application of norms and standards are constantly groping. The forum called for industry standards, and promote the orderly development of molecular diagnostics products.
You will see: Clinical Oncology, pathology, laboratory medicine physicians, medical testing companies and diagnostic products R & D Enterprises

(four) precision medicine research and Development Forum (three 12.17-18)
Forum features: in today's cancer immunotherapy and targeted treatment of drug development in the era of white hot, how to put aside the traditional thinking of drug development? How to develop new drugs to speed up the development of non clinical and clinical development of the process? The research on the downstream cooperation to pharmaceutical companies, seeking the best strategy for the development of the cost reduction? Precision pharmaceutical R & D forum will give you the answer.
You will see: Pharmaceutical Enterprises R & D department, Department of strategic transformation, medicine, preclinical development, clinical development and medical department, Biotech Corp R & D department - R & D department P4 China cell therapy for industry colleagues to create a set of meetings, exhibitions and special events in a precise medical community dialogue exchanges and cooperation the important event of the year.  
Focus, Europe, the United States, Asia precision medical field leader in leading practice, you can not miss the professional international event! Will be dedicated to helping the government, production, learning and research, multi information aggregation, the policy regulation, capital, technology, application, business integration, through the viewpoints and benefit by mutual discussion to boost the development of the medical industry, precision.